Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.
The proposed diagnostic platform will be able to identify and determine resistance of bloodstream infections within three hours.
The quantitative paper-based DNA reader (qPDR) takes advantage of a recently discovered interaction between SYBR Green I and cellulose paper.
A test being developed by researchers at Stanford University and Enable Biosciences could be used for HIV screening sooner than traditional immunoassays.
The Salt Lake City-based firm expects to launch a test in the infertility space this year and is also involved in endometriosis therapeutics development.
The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.
The new instrument has higher throughput than competing systems, while the flu test boasts enhanced sensitivity and protection against seasonal drift.
The lab will launch a carrier screening test this year, and plans to bring infectious disease, allergy, cognitive health, and toxicology tests as well.
The sequencing-based, laboratory-developed test, called SmartJane, contains the first commercially available vaginal microbiome assay.
The Finnish firm provided updates on its isothermal amplification-based molecular diagnostics technology as well as its broader diagnostics business.
The recent study highlights strengths and weaknesses of numerous platforms and may help end users choose the best assay for their circumstances.